Author:
Bender Brendan,Leipold Douglas D.,Xu Keyang,Shen Ben-Quan,Tibbitts Jay,Friberg Lena E.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Chen J, Jaracz S, Zhao X, Chen S, Ojima I. Antibody–cytotoxic agent conjugates for cancer therapy. Expert Opin Drug Deliv. 2005;2(5):873–90.
2. Wu AM, Senter PD. Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol. 2005;23(9):1137–46.
3. Lopus M. Antibody–DM1 conjugates as cancer therapeutics. Cancer Lett. 2011;307(2):113–8.
4. Chari RV, Martell BA, Gross JL, Cook SB, Shah SA, Blattler WA, et al. Immunoconjugates containing novel maytansinoids: promising anticancer drugs. Cancer Res. 1992;52(1):127–31.
5. Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, et al. Targeting HER2-positive breast cancer with trastuzumab emtansine, an antibody–cytotoxic drug conjugate. Cancer Res. 2008;68(22):9280–90.
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献